/NVZMY

NVZMY Stock - Novozymes A/S

Q: What is the analyst price target for NVZMY?

Analyst price target information is not currently available for NVZMY.

Q: What is NVZMY's market cap?

Market capitalization information is not currently available for NVZMY.

Basic Materials|Chemicals - Specialty|OTC

$63.31+0.21%

+$0.13 (+0.21%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $69.64

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NVZMY

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.79

52W High$75.99

52W Low$53.95

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$3.83B	$17.90B	$17.55B	$14.95B	$14.01B
Gross Profit	$1.81B	$9.72B	$9.58B	$8.62B	$7.85B
Gross Margin	47.2%	54.3%	54.6%	57.7%	56.0%
Operating Income	$659.00M	$3.98B	$4.63B	$4.01B	$3.65B
Net Income	$305.80M	$3.02B	$3.68B	$3.15B	$2.83B
Net Margin	8.0%	16.9%	20.9%	21.0%	20.2%
EPS	$1.10	$1.46	$13.29	$11.32	$10.07

Company Overview

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

25%

Hold / Neutral

25%

Sell / Underperform

50%

Analyst Consensus🔴 Bearish

1 Bullish3 Neutral/Bearish

Price Targets

Average Target

↓ 92.1% Downside

Now

Low

Average

High

Based on 1 analyst

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
October 17th 2024	Citigroup	Downgrade	Sell	-
November 13th 2023	UBS	Upgrade	Neutral	$5
October 30th 2023	Deutsche Bank	Upgrade	Buy	-
December 7th 2022	JP Morgan	Upgrade	Overweight	-
October 10th 2022	Exane BNP Paribas	Downgrade	Underperform	-

Earnings History & Surprises

NVZMY

Beat Rate

37%

Last 19 quarters

Avg Surprise

-36.6%

EPS vs Estimate

Beats / Misses

7/12

Last 12 quarters

Latest EPS

$0.05

Q4 2025

EPS Surprise History

Q1 24

-23.4%

$0.36vs$0.47

Q2 24

-78.0%

$0.12vs$0.56

Q3 24

-82.7%

$0.12vs$0.71

Q4 24

-16.7%

$0.48vs$0.57

Q1 25

-93.3%

$0.07vs$1.10

Q2 25

-86.5%

$0.06vs$0.44

Q3 25

-93.2%

$0.05vs$0.67

Q4 25

-88.4%

$0.05vs$0.47

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 25, 2026	—	—	—	—
Q4 2025	Nov 6, 2025	$0.47	$0.05	-88.4%	✗ MISS
Q3 2025	Aug 21, 2025	$0.67	$0.05	-93.2%	✗ MISS
Q2 2025	May 8, 2025	$0.44	$0.06	-86.5%	✗ MISS
Q1 2025	Feb 27, 2025	$1.10	$0.07	-93.3%	✗ MISS
Q4 2024	Nov 28, 2024	$0.57	$0.48	-16.7%	✗ MISS
Q3 2024	Aug 28, 2024	$0.71	$0.12	-82.7%	✗ MISS
Q2 2024	May 29, 2024	$0.56	$0.12	-78.0%	✗ MISS
Q1 2024	Feb 1, 2024	$0.47	$0.36	-23.4%	✗ MISS
Q4 2023	Oct 26, 2023	$0.42	$0.49	+16.7%	✓ BEAT
Q3 2023	Aug 9, 2023	$0.42	$0.32	-23.8%	✗ MISS
Q2 2023	Apr 26, 2023	$2.99	$2.82	-5.7%	✗ MISS
Q1 2023	Jan 26, 2023	$0.41	$0.44	+7.8%	✓ BEAT
Q4 2022	Nov 3, 2022	$0.54	$0.56	+3.7%	✓ BEAT
Q3 2022	Aug 11, 2022	$0.39	$0.41	+5.1%	✓ BEAT
Q2 2022	Apr 26, 2022	$0.43	$0.45	+4.0%	✓ BEAT
Q1 2022	Feb 1, 2022	$2.38	$0.36	-84.9%	✗ MISS
Q4 2021	Oct 26, 2021	$2.56	$0.48	-81.3%	✗ MISS
Q3 2021	Aug 12, 2021	$0.41	$0.46	+12.2%	✓ BEAT
Q2 2021	Apr 27, 2021	$0.45	$0.51	+13.3%	✓ BEAT

Frequently Asked Questions about NVZMY

What is NVZMY's current stock price?

Novozymes A/S (NVZMY) is currently trading at $63.31 per share. The stock has moved +0.21% today.

What is the analyst price target for NVZMY?

No analyst price targets are currently available for this stock.

What sector is Novozymes A/S in?

Novozymes A/S operates in the Basic Materials sector, specifically within the Chemicals - Specialty industry. The company is traded on the OTC exchange.

What is NVZMY's market cap?

Novozymes A/S has a market capitalization of $29.58 billion, making it a large-cap company.

Does NVZMY pay dividends?

No, Novozymes A/S does not currently pay a dividend to shareholders.